Patients with inflammatory bowel disease (IBD) reported mostly favorable responses with the use of mail-order kits for stool ...

"Mainz Biomed partners with Quest for colorectal cancer screening test" was originally created and published by Medical ...

Mainz Biomed has announced a partnership with Quest Diagnostics to support the ... technology to detect cancerous DNA in stool samples and is poised to enhance early detection of this malignancy.

Through polymerase chain reaction (PCR) technology, a small sample of DNA can be examined through a patient’s stool sample to identify ... in preliminary data. Quest will provide clinical ...